134 related articles for article (PubMed ID: 2469277)
1. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
[TBL] [Abstract][Full Text] [Related]
2. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
[TBL] [Abstract][Full Text] [Related]
3. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
Velasco F; Torres A; Andres P; Martinez F; Gomez P
Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
[TBL] [Abstract][Full Text] [Related]
4. Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia.
Bratt G; Blombäck M; Paul C; Schulman S; Törnebohm E; Lockner D
Scand J Haematol; 1985 Apr; 34(4):332-9. PubMed ID: 3858983
[TBL] [Abstract][Full Text] [Related]
5. A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia.
Sureda A; García Frade LJ; Torrado MC; García Laraña J; García Avello A
Acta Haematol; 1992; 88(2-3):100-4. PubMed ID: 1281598
[TBL] [Abstract][Full Text] [Related]
6. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
[TBL] [Abstract][Full Text] [Related]
7. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
[No Abstract] [Full Text] [Related]
8. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
Castaman G; Ruggeri M; Rodeghiero F
Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
[No Abstract] [Full Text] [Related]
9. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
García Frade LJ; García Avello A
Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
[No Abstract] [Full Text] [Related]
10. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
[TBL] [Abstract][Full Text] [Related]
11. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
13. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
[TBL] [Abstract][Full Text] [Related]
14. High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemia.
García Frade LJ; Sureda A; Torrado MC; García Avello A
Acta Haematol; 1992; 88(1):7-10. PubMed ID: 1414164
[TBL] [Abstract][Full Text] [Related]
15. Roles of protein C, protein S, and antithrombin III in acute leukemia.
Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
[TBL] [Abstract][Full Text] [Related]
16. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
17. Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.
Pabinger I; Bettelheim P; Dudczak R; Hinterberger W; Kyrle PA; Niessner H; Schwarzinger I; Speiser W; Lechner K
Ann Hematol; 1991 May; 62(5):174-9. PubMed ID: 2049464
[TBL] [Abstract][Full Text] [Related]
18. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
[No Abstract] [Full Text] [Related]
19. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
von Kries R; Ebell W; Jürgens H; Göbel U
Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
[TBL] [Abstract][Full Text] [Related]
20. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]